ArticleJournal of inflammation research2023

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview.

Mohammed Safi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.